Tyck till om SwePub Sök
här!
Sökning: WFRF:(Schott Jonathan M)
> (2020)
> Lunn Michael P >
Cerebrospinal Fluid...
Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
-
Banerjee, Gargi (författare)
-
Ambler, Gareth (författare)
-
Keshavan, Ashvini (författare)
-
visa fler...
-
Paterson, Ross W (författare)
-
Foiani, Martha S (författare)
-
Toombs, Jamie (författare)
-
Heslegrave, Amanda (författare)
-
Dickson, John C (författare)
-
Fraioli, Francesco (författare)
-
Groves, Ashley M (författare)
-
Lunn, Michael P (författare)
-
Fox, Nick C (författare)
-
- Zetterberg, Henrik, 1973 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
-
Schott, Jonathan M (författare)
-
Werring, David J (författare)
-
visa färre...
-
(creator_code:org_t)
- 2020
- 2020
- Engelska.
-
Ingår i: Journal of Alzheimer's disease : JAD. - 1875-8908. ; 74:4, s. 1189-1201
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.3...
-
visa färre...
Abstract
Ämnesord
Stäng
- There is limited data on cerebrospinal fluid (CSF) biomarkers in sporadic amyloid-β (Aβ) cerebral amyloid angiopathy (CAA).To determine the profile of biomarkers relevant to neurodegenerative disease in the CSF of patients with CAA.We performed a detailed comparison of CSF markers, comparing patients with CAA, Alzheimer's disease (AD), and control (CS) participants, recruited from the Biomarkers and Outcomes in CAA (BOCAA) study, and a Specialist Cognitive Disorders Service.We included 10 CAA, 20 AD, and 10 CS participants (mean age 68.6, 62.5, and 62.2 years, respectively). In unadjusted analyses, CAA patients had a distinctive CSF biomarker profile, with significantly lower (p<0.01) median concentrations of Aβ38, Aβ40, Aβ42, sAβPPα, and sAβPPβ. CAA patients had higher levels of neurofilament light (NFL) than the CS group (p<0.01), but there were no significant differences in CSF total tau, phospho-tau, soluble TREM2 (sTREM2), or neurogranin concentrations. AD patients had higher total tau, phospho-tau and neurogranin than CS and CAA groups. In age-adjusted analyses, differences for the CAA group remained for Aβ38, Aβ40, Aβ42, and sAβPPβ. Comparing CAA patients with amyloid-PET positive (n=5) and negative (n=5) scans, PET positive individuals had lower (p<0.05) concentrations of CSF Aβ42, and higher total tau, phospho-tau, NFL, and neurogranin concentrations, consistent with an "AD-like" profile.CAA has a characteristic biomarker profile, suggestive of a global, rather than selective, accumulation of amyloid species; we also provide evidence of different phenotypes according to amyloid-PET positivity. Further replication and validation of these preliminary findings in larger cohorts is needed.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Neurosciences (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Banerjee, Gargi
-
Ambler, Gareth
-
Keshavan, Ashvin ...
-
Paterson, Ross W
-
Foiani, Martha S
-
Toombs, Jamie
-
visa fler...
-
Heslegrave, Aman ...
-
Dickson, John C
-
Fraioli, Frances ...
-
Groves, Ashley M
-
Lunn, Michael P
-
Fox, Nick C
-
Zetterberg, Henr ...
-
Schott, Jonathan ...
-
Werring, David J
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Neurovetenskaper
- Artiklar i publikationen
-
Journal of Alzhe ...
- Av lärosätet
-
Göteborgs universitet